Ex Parte WEINSTEIN et al - Page 5




              Appeal No. 2002-1404                                                                Page 5                
              Application No. 08/891,918                                                                                


              although "the suggestion more often comes from the teachings of the pertinent                             
              references," In re Rouffet, 149 F.3d 1350, 1355, 47 USPQ2d 1453, 1456 (Fed. Cir.                          
              1998).  The range of sources available, however, does not diminish the requirement for                    
              actual evidence.  A broad conclusory statement regarding the obviousness of modifying                     
              a reference, standing alone, is not "evidence."  Thus, when an examiner relies on                         
              general knowledge to negate patentability, that knowledge must be articulated and                         
              placed on the record.  See In re Lee, 277 F.3d 1338, 1342-45, 61 USPQ2d 1430, 1433-                       
              35 (Fed. Cir. 2002).  See also In re Dembiczak, 175 F.3d 994, 999, 50 USPQ2d 1614,                        
              1617 (Fed. Cir. 1999).                                                                                    


                     In our view, the combined teachings of the applied prior art would not have made                   
              it obvious at the time the invention was made to a person of ordinary skill in the art to                 
              have prepared a prepackaged blister pack for providing a therapeutic regimen lasting at                   
              least ten days for treating sinusitis which incorporates (1) a plurality of dosages of an                 
              oral antibiotic effective for treating sinusitis caused by at least one of the organisms                  
              from the class consisting of Streptococcus pneumoniae, Haemophilis influenza, and                         
              Moraxella catarrhalis; (2) a plurality of dosages of at least one active treatment oral                   
              medication selected from the class consisting of decongestant, expectorant, mucolytic,                    
              anti-inflammatory agent, cell stabilizer, and mediator antagonist; and (3) instructions for               
              coordinating use of the dosages together.  In that regard, we see no motivation,                          








Page:  Previous  1  2  3  4  5  6  7  8  9  Next 

Last modified: November 3, 2007